Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Currency Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack NCDEX Tips and Free Stock Tips. We provide services in equity, commodity and Forex market.

1. HEADLINES
 Indian Market
Indian equity markets up by 0.00%.
Nifty up by 0.15 pts and settle at 5571.55
Sensex down by 9.68 pts at 18329.32.
Bank Nifty up by 11.35 pts at 11318.30
 Global Market
DAILY EQUITY European markets were down with FTSE
down by 4.75 pts at 5723.91,CAC down
NEWSLETTER by 4.14 pts at 3435.44 and DAX up by
18.54 pts at 7142.38
21ST NOVEMBER 2012
Dow future up by 5.00 pts at 12743.00
 HEADLINES
• RIL softens stance over proposed CAG
audit: Sources
• Govt considering raising FII limit in
bonds: Source
• Techno Electric: May not see 8-10%
growth in FY13 EPC sales
• TPG interested to pick up stakes in
Kingfisher: Sources
WWW.EPICRESEARCH.CO 09752199966

2.  MARKET ANALYSIS:
 High volatility was witnessed during the last one hour or so of trade as key benchmark indices
recovered after hitting fresh intraday low. The barometer index, BSE Sensex, recovered after hitting its
lowest level in over 9-1/2 weeks. The 50-unit S&P CNX Nifty regained positive zone after hitting its
lowest level in 6-1/2 weeks.
 The BSE Sensex was down 9.74 points or 0.05% to 18,329.26.
 The S&P CNX Nifty was up 1.85 points or 0.03% to 5,573.25, as per provisional figures.
 From the 30-share Sensex pack, 16 stocks declined while the rest of them rose.
 Among other capital goods stocks, Siemens, BEML, Bhel, Thermax and Punj Lloyd shed by between
0.42% to 1.6%.Capital goods stocks extended recent losses. L&T was down 0.5%. The company
announced during trading hours today, 20 November 2012, that its construction division has won new
orders worth over Rs 2503 crore across various business segments. Pharma major Lupin rose 1% after
the company announced today, 20 November 2012, that its subsidiary Lupin Pharmaceuticals Inc. has
launched its Fenofibrate Tablets, 48 mg and 145 mg strengths in the United States.
STOCKS TO WATCH
 FII’s and DII’s  JP ASSOCIATE
CATEGORY DATE BUY SELL NET  AMBUJA
FII 20-Nov-12 2377.81 2234.43 143.38  HAVELLS
 JET AIRWAYS
DII 20-Nov-12 769.65 781.18 -11.53
SCRIPS IN BAN PERIOD
 NIFTY DAILY PIVOTS
 SUZLON
PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 5772 5707 5642 5606 5577 5541 5512 5447 5382  PUNJLYOD
 WELCORP
WWW.EPICRESEARCH.CO 09752199966

3. .
 GAINERS AND LOOSERS
EXPERT OPINION
NIFTY
DAILY NIFTY GAINERS
 Nifty looks Sideways
SCRIPS RATE VOL. PR. NET %  Strategy: Buy on dips
(000) CLOSE CHAN CHANG
GE E  Support:5530
M&M 938.50 2540.04 908.80 29.70 3.27
 Resistance: 5610
BANK NIFTY
HDFC 782.05 2979.23 764.85 17.20 2.25
 Bank Nifty looks Sideways
Power
Grid 122.10 3277.16 120.05 2.05 1.71  Strategy: Buy on dips
Corpn.
 Support:11240
IDFC 157.00 5701.17 154.40 2.60 1.68
 Resistance:11390
Tata
98.45 4143.07 96.85 1.60 1.65
Power 
PREVIOUS PERFORMANCE
DAILY NIFTY LOOSERS TYPE SCRIP B/S RESULT
SCRIPS RATE VOL. PR. NET % NOT
CASH EXIDE B
(000) CLOSE CHAN CHA EXECUTED
GE NGE TGT
CASH DELTA CORP S
ACHEIVED
JP
85.90 18051.18 89.15 -3.25 -3.65 TGT
Associate FUTURE AMBUJA S
ACHEIVED
DLF 199.70 6226.86 204.55 -4.85 -2.37 NOT
FUTURE HDIL B
EXECUTED
Reliance
449.95 1591.63 458.80 -8.85 -1.93
Infra
Ambuja
195.75 1662.16 199.40 -3.65 -1.83
Cement
Hindalco 105.60 5767.87 107.55 -1.95 -1.81
09752199966

4. MARKET CALLS
CASH
ST ND
SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS
JP ASSOCIATE SELL 85.40 84.60 83.60 86.20
JET AIRWAYS BUY 417.00 421.00 426.00 413.00
FUTURE
ST ND
SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS
.
AMBUJA SELL 195.50 194.50 193.00 196.50
HAVELLS BUY 583.00 587.00 593.00 579.00
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on
sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of
the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoev er for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to
buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls
or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious
Legal Actions can be taken.